Abbott Laboratories 2013 Annual Report Download - page 57

Download and view the complete annual report

Please find page 57 of the 2013 Abbott Laboratories annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 76

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76

ABBOTT 2013 ANNUAL REPORT
55
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 15 — QUARTERLY RESULTS (UNAUDITED)
(in millions except per share data) 2013 2012
First Quarter
Continuing Operations:
Net Sales $5,378 $5,284
Gross Profit 2,747 2,716
Earnings from Continuing Operations 545 351
Basic Earnings per Common Share 0.35 0.22
Diluted Earnings per Common Share 0.34 0.22
Net Earnings 545 1,242
Basic Earnings per Common Share (a) 0.35 0.79
Diluted Earnings per Common Share (a) 0.34 0.78
Market Price per Share-High (b) 35.34 29.42
Market Price per Share-Low (b) 31.64 25.82
Second Quarter
Continuing Operations:
Net Sales $5,446 $5,313
Gross Profit 2,704 2,748
Earnings from Continuing Operations 476 411
Basic Earnings per Common Share 0.30 0.26
Diluted Earnings per Common Share 0.30 0.26
Net Earnings 476 1,725
Basic Earnings per Common Share (a) 0.30 1.09
Diluted Earnings per Common Share (a) 0.30 1.08
Market Price per Share-High (b) 38.77 30.85
Market Price per Share-Low (b) 34.69 28.25
Third Quarter
Continuing Operations:
Net Sales $5,369 $5,265
Gross Profit 2,722 2,581
Earnings from Continuing Operations 773 339
Basic Earnings per Common Share 0.50 0.21
Diluted Earnings per Common Share 0.49 0.21
Net Earnings 966 1,943
Basic Earnings per Common Share (a) 0.62 1.22
Diluted Earnings per Common Share (a) 0.61 1.21
Market Price per Share-High (b) 37.16 33.69
Market Price per Share-Low (b) 32.70 30.39
Fourth Quarter
Continuing Operations:
Net Sales $5,655 $5,632
Gross Profit 2,844 2,837
Earnings (loss) from Continuing Operations 589 (522)
Basic Earnings per Common Share 0.38 (0.33)
Diluted Earnings per Common Share 0.37 (0.33)
Net Earnings 589 1,053
Basic Earnings per Common Share (a) 0.38 0.66
Diluted Earnings per Common Share (a) 0.37 0.66
Market Price per Share-High (b) 38.81 34.67
Market Price per Share-Low (b) 32.75 29.96
(a) The sum of the four quarters of earnings per share for 2013 and 2012 may not
add to the full year earnings per share amount due to rounding and/or the use of
quarter-to-date weighted average shares to calculate the earnings per share amount
in each respective quarter.
(b) The 2012 market prices per share reflect historical share prices that have been adjusted
to reflect the separation of AbbVie.